Trial intelligence / Profile preview

Exosome therapy versus platelet-rich plasma for pattern hair loss

IRCT20160427027636N9Phase 2Completed

Sponsor
Mazandaran University of Medical Sciences
Start
Aug 2025
Countries
1
01

Overview

Phase 2, open-label trial of platelet-rich plasma in androgenetic alopecia (AGA) (3 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoint: Blinded Investigator Global Aesthetic Improvement Scale. Started Aug 2025; status: completed.

02

Drugs

platelet-rich plasma
03

Conditions

androgenetic alopecia (AGA)

Beyond the preview

Go deeper on IRCT20160427027636N9.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20160427027636N9.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call